2020
DOI: 10.1186/s12931-020-01495-w
|View full text |Cite
|
Sign up to set email alerts
|

Oxidative stress mediates the apoptosis and epigenetic modification of the Bcl-2 promoter via DNMT1 in a cigarette smoke-induced emphysema model

Abstract: Background Emphysema is a crucial pathological characteristic of chronic obstructive pulmonary disease (COPD). Oxidative stress, apoptosis and epigenetic mechanisms contribute to the pathogenesis of emphysema. However, an attempt to accurately identify whether these mechanisms interact with each other and how they are triggered has never been conducted. Method The total reactive oxygen species (ROS) level, pulmonary apoptosis and B-cell lymphoma/leukemia-2 (Bcl-2) expre… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
23
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 31 publications
(31 citation statements)
references
References 48 publications
4
23
0
Order By: Relevance
“…DNMTs-mediated aberrant methylation is linked to the pathogenesis and development of COPD ( Adcock et al, 2011 ). DNMT1 expression in the lung tissue from COPD patients was higher than that in the lung tissue from non-smokers ( Zeng et al, 2020 ).…”
Section: Resultsmentioning
confidence: 99%
“…DNMTs-mediated aberrant methylation is linked to the pathogenesis and development of COPD ( Adcock et al, 2011 ). DNMT1 expression in the lung tissue from COPD patients was higher than that in the lung tissue from non-smokers ( Zeng et al, 2020 ).…”
Section: Resultsmentioning
confidence: 99%
“…Morphometry was quantified by the values of mean linear intercept (MLI) at a magnification of 100× as previously described. 18 MLI was assessed by dividing the length of a line drawn across the section by the total number of intercepts encountered in 36 lines per sample, and 10 random fields per sample were observed by microscopy. The numbers of apoptotic cells in longitudinal lung sections from control and emphysema mice were quantified by In-situ Apoptosis Detection Kit (Nanjing Keygen Biotech, China).…”
Section: Methodsmentioning
confidence: 99%
“…Venetoclax was the first selective BCL-2 inhibitor to be approved for the treatment of chronic lymphocytic leukemia and acute myeloid leukemia [186]. Zeng, et al suggested the involvement of BCL-2 in the pathogenesis of COPD [187]. BCL-2 inhibitors may have anti-neoplastic as well as anti-inflammatory and anti-aging properties.…”
Section: B-cell Lymphoma-2 (Bcl-2) Inhibitorsmentioning
confidence: 99%